FFA
XERS icon

Farther Finance Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Farther Finance Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9K Sell
2,469
-102
-4% -$676 ﹤0.01% 3851
2025
Q4 		$20.2K Buy
2,571
+190
+8% +$1.5K ﹤0.01% 3433
2025
Q3 		$19.4K Buy
2,381
+2,200
+1,215% +$14.6K ﹤0.01% 3061
2025
Q2 		$845 Hold
181
– – ﹤0.01% 3938
2025
Q1 		$919 Hold
181
– – ﹤0.01% 3636
2024
Q4 		$614 Hold
181
– – ﹤0.01% 3400
2024
Q3 		$516 Buy
181
+7
+4% +$18 ﹤0.01% 3418
2024
Q2 		$378 Buy
174
+71
+69% +$143 ﹤0.01% 3339
2024
Q1 		$220 Hold
103
– – ﹤0.01% 3248
2023
Q4 		$242 Buy
+103
New +$190 ﹤0.01% 3186

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return